Adirondack Trust Company’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Buy
138,162
+8,060
+6% +$203K 1.04% 23
2026
Q1
$3.29M Buy
130,102
+50,952
+64% +$1.3M 1.1% 22
2025
Q4
$2.02M Buy
79,150
+14,722
+23% +$377K 0.66% 40
2025
Q3
$1.65M Buy
64,428
+9,171
+17% +$233K 0.55% 45
2025
Q2
$1.4M Buy
55,257
+7,250
+15% +$180K 0.51% 48
2025
Q1
$1.2M Buy
48,007
+16,954
+55% +$419K 0.47% 54
2024
Q4
$763K Buy
31,053
+20,361
+190% +$510K 0.29% 72
2024
Q3
$275K Buy
10,692
+1,945
+22% +$49.1K 0.11% 123
2024
Q2
$215K Buy
8,747
+3,529
+68% +$86.2K 0.09% 137
2024
Q1
$129K Buy
5,218
+662
+15% +$16.4K 0.05% 167
2023
Q4
$112K Buy
+4,556
New +$109K 0.05% 170

Other funds holding IBDX

Adirondack Trust Company's IBDX Position: Q2 2026 in Review

Adirondack Trust Company increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 6.2% in Q2 2026, buying an estimated $203K and bringing the position to 138,162 shares worth $3.48M. The position accounts for 1.04% of the portfolio, ranked #23.

Adirondack Trust Company first reported a position in IBDX in Q4 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Adirondack Trust Company held 138,162 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $3.48M as of Q2 2026.
  • Adirondack Trust Company bought 8,060 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $203K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.04% of Adirondack Trust Company's portfolio in Q2 2026, its #23 holding.
  • Adirondack Trust Company first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.